Blood Loss, Surgical Clinical Trial
Official title:
Effect of Monopolar Tungsten Needle Electrodes and Teflon Coated Spatula Electrodes on Blood Loss and Intraoperative Transfusions in Musculoskeletal Tumor Surgery Compared to Conventional Surgical Knives and Stainless-Steel Electrodes
Resection of malign musculoskeletal tumors and reconstruction with large tumor prostheses often results in relevant blood loss requiring hemodynamic stabilization and transfusion. The use of novel electrosurgical electrodes is assessed retrospectively regarding the potential to reduce blood loss and the need for transfusions.
Background Resection of malign musculoskeletal tumors and reconstruction with large tumor prostheses often result in relevant blood loss requiring hemodynamic stabilization and transfusion. Since machine autotransfusion is contraindicated in tumor surgery, other measures are necessary to reduce intraoperative blood loss. Objectives Tungsten needle electrodes can be used to simultaneously cut skin and seal bleeding vessels for superficial dissection. Spatula electrodes coated with Teflon (polytetrafluoroethylene PTFE) are used for coagulation and dissection of deeper tissues. The coating reduces eschar build-up and thus smoke creation compared to conventional stainless-steel electrodes. This study assesses the effect of these novel electrodes on blood loss and transfusion rates. Methods: The investigators retrospectively investigate all cases of tumor resection and reconstruction with tumor prostheses that were operated five years before the introduction of the new electrodes (2012-2016) and five years after (2018-2021) by one single surgeon with over 25 years of experience. Data are extracted from digital patient records and analyzed by descriptive statistics and t-test for normally distributed data or Mann-Whitney test in case of non-normal distribution. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04114253 -
QStat in Liver Transplant
|
||
Recruiting |
NCT05077124 -
Safe and Timely Antithrombotic Removal (STAR) Registry
|
||
Active, not recruiting |
NCT03651154 -
Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections
|
N/A | |
Recruiting |
NCT04519593 -
ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma
|
N/A | |
Completed |
NCT02043132 -
Tranexamic Acid in Reverse Total Shoulder Arthroplasty
|
Phase 2/Phase 3 | |
Withdrawn |
NCT00861367 -
Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate
|
N/A | |
Terminated |
NCT03246919 -
Ideal Time of Oxytocin Infusion During Cesarean Section
|
Phase 4 | |
Completed |
NCT04443920 -
Tranexamic Acid for Total Knee Arthroscopy
|
Phase 4 | |
Withdrawn |
NCT04933253 -
Mediastinal Temperature and Post-operative Bleeding
|
N/A | |
Recruiting |
NCT02938962 -
Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)
|
Phase 4 | |
Recruiting |
NCT02130752 -
Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma Surgery
|
N/A | |
Not yet recruiting |
NCT04574128 -
Retransfusion or Not of Cardiotomy Blood
|
N/A | |
Completed |
NCT02911831 -
IV Tranexamic Acid Prior to Hysterectomy
|
Early Phase 1 | |
Completed |
NCT02740374 -
Evaluation of Thromboelastometry (ROTEM) During Spinal Surgery
|
N/A | |
Enrolling by invitation |
NCT05474027 -
Reducing Hypotensive Anesthesia Use With TXA During Orthognathic Surgery
|
Phase 4 | |
Completed |
NCT05391607 -
Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement
|
Phase 4 | |
Completed |
NCT03152461 -
Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge
|
||
Recruiting |
NCT02441751 -
Intraoperative Volume Management and QT Interval
|
||
Completed |
NCT01053169 -
Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)
|
N/A | |
Completed |
NCT00656396 -
Point of Care Coagulation Testing in Patients Undergoing Major Surgery
|
Phase 3 |